NeueHealth Historical Balance Sheet

NEUE Stock

7.29 0.06 0.82%

Trend analysis of NeueHealth balance sheet accounts such as Total Current Liabilities of 1.8 B provides information on NeueHealth's total assets, liabilities, and equity, which is the actual value of NeueHealth to its prevalent stockholders. By breaking down trends over time using NeueHealth balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining NeueHealth latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether NeueHealth is a good buy for the upcoming year.

NeueHealth Inventory

1.34 Billion

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.

About NeueHealth Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of NeueHealth at a specified time, usually calculated after every quarter, six months, or one year. NeueHealth Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of NeueHealth and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which NeueHealth currently owns. An asset can also be divided into two categories, current and non-current.

NeueHealth Balance Sheet Chart

At present, NeueHealth's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 1.4 B, whereas Retained Earnings are projected to grow to (3.7 B).

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Total Assets

Total assets refers to the total amount of NeueHealth assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in NeueHealth books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on NeueHealth balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of NeueHealth are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from NeueHealth's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into NeueHealth current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.At present, NeueHealth's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 1.4 B, whereas Retained Earnings are projected to grow to (3.7 B).

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	303.9M	370.3M	425.9M	447.2M
Total Assets	4.7B	1.2B	1.4B	2.7B

Short Long Term Debt Total Total Assets

NeueHealth balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Receivables
Total Assets		0.56	0.95	0.94	0.04	0.63	0.11	0.58	-0.56	0.43	-0.58	0.79	0.77	-0.35	0.77	-0.42	-0.11	0.1	-0.25	0.63	0.92	0.95	0.59	0.74	0.2	0.45
Short Long Term Debt Total	0.56		0.69	0.75	-0.57	0.21	0.87	1.0	-0.99	0.36	-0.99	0.14	0.08	-0.85	0.11	0.19	-0.5	-0.08	0.14	0.93	0.7	0.63	0.74	0.49	-0.34	0.94
Other Current Liab	0.95	0.69		0.99	0.01	0.53	0.24	0.7	-0.7	0.27	-0.7	0.66	0.7	-0.57	0.61	-0.23	-0.36	-0.09	-0.19	0.76	0.89	0.97	0.59	0.6	0.01	0.62
Total Current Liabilities	0.94	0.75	0.99		-0.1	0.52	0.33	0.77	-0.77	0.37	-0.77	0.66	0.66	-0.59	0.62	-0.22	-0.33	-0.03	-0.13	0.81	0.93	0.96	0.67	0.67	0.02	0.7
Total Stockholder Equity	0.04	-0.57	0.01	-0.1		0.48	-0.78	-0.55	0.56	-0.42	0.54	0.35	0.61	0.22	0.34	-0.54	-0.17	-0.55	0.15	-0.23	-0.32	-0.07	-0.74	-0.12	0.59	-0.54
Property Plant And Equipment Net	0.63	0.21	0.53	0.52	0.48		-0.08	0.24	-0.18	0.41	-0.27	0.82	0.83	-0.24	0.81	-0.83	-0.19	-0.29	0.44	0.49	0.39	0.39	0.01	0.76	0.78	0.16
Current Deferred Revenue	0.11	0.87	0.24	0.33	-0.78	-0.08		0.85	-0.83	0.31	-0.85	-0.25	-0.37	-0.74	-0.26	0.4	-0.4	-0.02	0.3	0.71	0.34	0.18	0.6	0.26	-0.46	0.83
Net Debt	0.58	1.0	0.7	0.77	-0.55	0.24	0.85		-0.99	0.41	-1.0	0.2	0.12	-0.84	0.17	0.13	-0.48	-0.07	0.17	0.93	0.72	0.63	0.75	0.54	-0.28	0.95
Retained Earnings	-0.56	-0.99	-0.7	-0.77	0.56	-0.18	-0.83	-0.99		-0.38	0.99	-0.18	-0.11	0.84	-0.15	-0.16	0.49	0.07	-0.14	-0.92	-0.72	-0.63	-0.76	-0.49	0.33	-0.96
Accounts Payable	0.43	0.36	0.27	0.37	-0.42	0.41	0.31	0.41	-0.38		-0.45	0.6	0.25	0.06	0.63	-0.49	0.48	0.61	0.2	0.29	0.58	0.24	0.69	0.87	0.45	0.38
Cash	-0.58	-0.99	-0.7	-0.77	0.54	-0.27	-0.85	-1.0	0.99	-0.45		-0.23	-0.15	0.83	-0.2	-0.09	0.47	0.06	-0.2	-0.94	-0.72	-0.62	-0.76	-0.57	0.24	-0.96
Non Current Assets Total	0.79	0.14	0.66	0.66	0.35	0.82	-0.25	0.2	-0.18	0.6	-0.23		0.92	0.03	1.0	-0.81	0.18	0.15	0.05	0.33	0.65	0.6	0.32	0.83	0.72	0.16
Non Currrent Assets Other	0.77	0.08	0.7	0.66	0.61	0.83	-0.37	0.12	-0.11	0.25	-0.15	0.92		-0.1	0.9	-0.75	-0.11	-0.19	0.04	0.35	0.52	0.62	0.07	0.61	0.65	0.09
Cash And Short Term Investments	-0.35	-0.85	-0.57	-0.59	0.22	-0.24	-0.74	-0.84	0.84	0.06	0.83	0.03	-0.1		0.07	-0.22	0.87	0.58	-0.36	-0.92	-0.36	-0.44	-0.3	-0.2	0.33	-0.83
Good Will	0.77	0.11	0.61	0.62	0.34	0.81	-0.26	0.17	-0.15	0.63	-0.2	1.0	0.9	0.07		-0.83	0.23	0.19	0.05	0.28	0.63	0.56	0.32	0.84	0.75	0.13
Common Stock Shares Outstanding	-0.42	0.19	-0.23	-0.22	-0.54	-0.83	0.4	0.13	-0.16	-0.49	-0.09	-0.81	-0.75	-0.22	-0.83		-0.23	0.0	-0.29	-0.05	-0.2	-0.13	0.11	-0.67	-0.93	0.21
Short Term Investments	-0.11	-0.5	-0.36	-0.33	-0.17	-0.19	-0.4	-0.48	0.49	0.48	0.47	0.18	-0.11	0.87	0.23	-0.23		0.89	-0.38	-0.67	0.01	-0.22	0.17	0.16	0.29	-0.49
Non Current Liabilities Total	0.1	-0.08	-0.09	-0.03	-0.55	-0.29	-0.02	-0.07	0.07	0.61	0.06	0.15	-0.19	0.58	0.19	0.0	0.89		-0.5	-0.36	0.34	0.06	0.58	0.28	-0.01	-0.1
Other Current Assets	-0.25	0.14	-0.19	-0.13	0.15	0.44	0.3	0.17	-0.14	0.2	-0.2	0.05	0.04	-0.36	0.05	-0.29	-0.38	-0.5		0.34	-0.31	-0.41	-0.24	0.24	0.45	0.28
Other Stockholder Equity	0.63	0.93	0.76	0.81	-0.23	0.49	0.71	0.93	-0.92	0.29	-0.94	0.33	0.35	-0.92	0.28	-0.05	-0.67	-0.36	0.34		0.64	0.64	0.53	0.56	-0.08	0.89
Total Liab	0.92	0.7	0.89	0.93	-0.32	0.39	0.34	0.72	-0.72	0.58	-0.72	0.65	0.52	-0.36	0.63	-0.2	0.01	0.34	-0.31	0.64		0.92	0.85	0.74	-0.01	0.63
Total Current Assets	0.95	0.63	0.97	0.96	-0.07	0.39	0.18	0.63	-0.63	0.24	-0.62	0.6	0.62	-0.44	0.56	-0.13	-0.22	0.06	-0.41	0.64	0.92		0.63	0.53	-0.09	0.53
Short Term Debt	0.59	0.74	0.59	0.67	-0.74	0.01	0.6	0.75	-0.76	0.69	-0.76	0.32	0.07	-0.3	0.32	0.11	0.17	0.58	-0.24	0.53	0.85	0.63		0.6	-0.24	0.73
Intangible Assets	0.74	0.49	0.6	0.67	-0.12	0.76	0.26	0.54	-0.49	0.87	-0.57	0.83	0.61	-0.2	0.84	-0.67	0.16	0.28	0.24	0.56	0.74	0.53	0.6		0.57	0.46
Common Stock	0.2	-0.34	0.01	0.02	0.59	0.78	-0.46	-0.28	0.33	0.45	0.24	0.72	0.65	0.33	0.75	-0.93	0.29	-0.01	0.45	-0.08	-0.01	-0.09	-0.24	0.57		-0.28
Net Receivables	0.45	0.94	0.62	0.7	-0.54	0.16	0.83	0.95	-0.96	0.38	-0.96	0.16	0.09	-0.83	0.13	0.21	-0.49	-0.1	0.28	0.89	0.63	0.53	0.73	0.46	-0.28

Click cells to compare fundamentals

NeueHealth Account Relationship Matchups

NeueHealth balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.8B	3.6B	4.7B	1.2B	1.4B	2.7B
Short Long Term Debt Total	28.4M	155M	303.9M	370.3M	425.9M	447.2M
Other Current Liab	223.6M	1.8B	3.4B	910.5M	1.0B	1.4B
Total Current Liabilities	565.3M	2.3B	3.7B	1.4B	1.6B	1.8B
Total Stockholder Equity	(503.7M)	1.1B	719.9M	(343.5M)	(309.2M)	(293.7M)
Property Plant And Equipment Net	12.3M	38.3M	21.3M	14.5M	16.7M	22.8M
Current Deferred Revenue	34.6M	2.6M	242K	281.9M	324.2M	340.4M
Net Debt	(460.0M)	(134.3M)	86.9M	283.0M	325.5M	341.8M
Retained Earnings	(516.0M)	(1.7B)	(3.2B)	(4.3B)	(3.9B)	(3.7B)
Accounts Payable	307.0M	321.1M	23.4M	169.7M	152.8M	136.9M
Cash	488.4M	289.3M	217.0M	87.3M	78.6M	74.6M
Non Current Assets Total	631.0M	1.9B	1.1B	136.6M	157.0M	149.2M
Non Currrent Assets Other	28.3M	713.2M	561.4M	28.8M	33.1M	31.5M
Cash And Short Term Investments	988.3M	433.8M	217.9M	93.6M	84.2M	80.0M
Common Stock Shares Outstanding	7.7M	4.9M	7.9M	8.0M	9.1M	8.0M
Short Term Investments	499.9M	144.5M	869K	6.3M	5.6M	5.4M
Liabilities And Stockholders Equity	1.8B	3.6B	4.7B	1.2B	1.4B	2.7B
Non Current Liabilities Total	1.7B	41.3M	32.2M	88.8M	80.0M	76.0M
Other Current Assets	131.0M	1.1B	46.5M	840.4M	966.5M	613.4M
Other Stockholder Equity	(1.7B)	2.8B	3.0B	3.0B	3.5B	3.7B
Total Liab	2.3B	2.3B	3.7B	1.5B	1.7B	2.2B
Total Current Assets	1.2B	1.7B	3.6B	1.1B	1.3B	1.8B
Accumulated Other Comprehensive Income	2.4M	(3.3M)	(4.4M)	(122K)	(109.8K)	(115.3K)
Short Term Debt	437.6M	155M	312.3M	311.0M	357.7M	268.3M
Intangible Assets	152.2M	337.0M	105.0M	93.2M	107.2M	155.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

When determining whether NeueHealth is a strong investment it is important to analyze NeueHealth's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NeueHealth's future performance. For an informed investment choice regarding NeueHealth Stock, refer to the following important reports:

How To Invest In NeueHealth

Details

Is NeueHealth Stock a good investment?

Details

What is NeueHealth's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.

You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeueHealth. If investors know NeueHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeueHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

4.07

Revenue Per Share

122.333

Quarterly Revenue Growth

(0.14)

Return On Assets

(0.05)

Return On Equity

(1.83)

The market value of NeueHealth is measured differently than its book value, which is the value of NeueHealth that is recorded on the company's balance sheet. Investors also form their own opinion of NeueHealth's value that differs from its market value or its book value, called intrinsic value, which is NeueHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeueHealth's market value can be influenced by many factors that don't directly affect NeueHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between NeueHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeueHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeueHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NeueHealth Historical Balance Sheet

NeueHealth Inventory

1.34 Billion

About NeueHealth Balance Sheet Analysis

NeueHealth Balance Sheet Chart

Total Assets

Total Current Liabilities

NeueHealth balance sheet Correlations

NeueHealth Account Relationship Matchups

High Positive Relationship

High Negative Relationship

NeueHealth balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Good Will	+ 1.0	Non Current Assets Total
Total Current Liabilities	+ 0.99	Other Current Liab
Cash	+ 0.99	Retained Earnings
Total Current Assets	+ 0.97	Other Current Liab
Total Current Assets	+ 0.96	Total Current Liabilities

Cash	- 1.0	Net Debt
Retained Earnings	- 0.99	Net Debt
Cash	- 0.99	Short Long Term Debt Total
Retained Earnings	- 0.99	Short Long Term Debt Total
Net Receivables	- 0.96	Cash
Net Receivables	- 0.96	Retained Earnings